Trial Profile
An Innovative Controlled Ovarian Hyperstimulation (COH) Protocol That Combines Large Oocyte Availability and Physiologic Estrogenic Environment for Good Prognosis In Vitro Fertilization and Embryo Transfer (IVF-ET) Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Cetrorelix (Primary) ; Follitropin alfa (Primary)
- Indications Infertility
- Focus Therapeutic Use
- Acronyms NATOS
- 29 Apr 2021 Status changed from active, no longer recruiting to completed.
- 27 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 16 Mar 2018 Planned End Date changed from 1 Dec 2018 to 1 Jun 2019.